Adamas to Present at Upcoming Needham Conference

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, Chief Executive Officer, will participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on April 12 – 15, 2021.

The fireside chat will be webcast live on April 14 from 3:00 Eastern Time on the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. The replay will be available for 30 days.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

Source: Adamas Pharmaceuticals, Inc.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  206.96
-1.76 (-0.84%)
AAPL  273.68
-0.94 (-0.34%)
AMD  213.57
-2.43 (-1.13%)
BAC  55.39
-1.02 (-1.81%)
GOOG  318.63
-5.77 (-1.78%)
META  670.72
-6.50 (-0.96%)
MSFT  413.27
-0.33 (-0.08%)
NVDA  188.54
-1.50 (-0.79%)
ORCL  159.89
+3.30 (2.11%)
TSLA  425.21
+7.89 (1.89%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.